Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | PAM | P19021 | 2/20 | 0.46 |
| ▸ | CES2 | O00748 | 4/20 | 0.44 |
| ▸ | CES1 | P23141 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | FAAH | O00519 | 1/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.42 |
| ▸ | NAAA | Q02083 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL666141 | 0.98 | DGKA (0.53) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL27593607 | 0.98 | DGKA (0.53) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL31155339 | 0.98 | DGKA (0.53) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL29126817 | 0.98 | DGKA (0.53) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL8883996 | 0.98 | DGKA (0.53) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL8882128 | 0.98 | DGKA (0.53) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL6879249 | 0.94 | ALDH1A1 (0.46) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL18126434 | 0.91 | TSHR (0.40) | DGKALMNAPAMALDH1A1MAPT | |
| SCHEMBL18126426 | 0.89 | DGKA (0.40) | DGKALMNAPAMALDH1A1MAPT | |
| SCHEMBL18126500 | 0.89 | DGKA (0.40) | DGKALMNAPAMALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021253746-A1 | USE OF DALBAVANCIN IN PREPARATION OF MEDICAMENT FOR INHIBITING BINDING OF SARS-COV-2 TO ACE2 | 中国科学院昆明动物研究所 | 2021-12-23 | — | — | WO | claimed |
| CN-116602963-A | Application of verteporfin in preparation of medicines for inhibiting pulmonary fibrosis | 中国人民解放军陆军特色医学中心 | 2023-08-18 | — | — | CN | disclosed |
| CN-113876796-A | Application of coumarin beta in preparation of medicine for inhibiting TRiC activity by targeting CCT4 | 中国科学院昆明动物研究所 | 2022-01-04 | — | — | CN | disclosed |
| WO-2021253746-A1 | USE OF DALBAVANCIN IN PREPARATION OF MEDICAMENT FOR INHIBITING BINDING OF SARS-COV-2 TO ACE2 | 中国科学院昆明动物研究所 | 2021-12-23 | — | — | WO | disclosed |
| CN-111686240-B | Application of dalbavancin in preparation of medicines for inhibiting combination of SARS-CoV-2 and ACE2 | 中国科学院昆明动物研究所 | 2021-04-09 | — | — | CN | disclosed |
| CN-111686240-A | Application of dalbavancin in preparation of medicines for inhibiting combination of SARS-CoV-2 and ACE2 | 中国科学院昆明动物研究所 | 2020-09-22 | — | — | CN | disclosed |
| JP-2004318111-A | COLORED PHOTOSENSITIVE RESIN COMPOSITION | SUMITOMO CHEM CO LTD | 2004-11-11 | — | — | JP | disclosed |